TMAO contributes to the early pathological process of atherosclerosis through accelerating endothelial activation and dysfunction, including reduced endothelial self-renewal and increased monocyte adhesion through activation of PKC/NF-κB/vascular cell adhesion molecule-1 (VCAM-1) [41]. Here, NFKB1 is linked to atherosclerosis.